Sargent Investment Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,634
| Closed | -$16.9K | – | 214 |
|
|
2023
Q2 | $16.9K | Buy |
25,634
+6,065
| +31% | +$4.01K | ﹤0.01% | 199 |
|
|
2023
Q1 | $15.1K | Sell |
19,569
-23,418
| -54% | -$18K | ﹤0.01% | 196 |
|
|
2022
Q4 | $97.2K | Buy |
42,987
+17,745
| +70% | +$40.1K | 0.03% | 184 |
|
|
2022
Q3 | $47K | Buy |
25,242
+7,454
| +42% | +$13.9K | 0.01% | 182 |
|
|
2022
Q2 | $66K | Buy |
17,788
+7,132
| +67% | +$26.5K | 0.02% | 180 |
|
|
2022
Q1 | $69K | Buy |
+10,656
| New | +$69K | 0.02% | 181 |
|